Nasdaq bcrx

BioCryst Pharmaceuticals, nasdaq bcrx, Inc. About the company. It is also developing BCX, an oral factor D inhibitor for complement-mediated diseases. Earnings are forecast to grow

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart.

Nasdaq bcrx

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which sections of the website you find most interesting and useful. See our Cookie Policy for more information. These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds. Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant. Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users. Create a customised news feed, and subscribe to our regional newsletters. BioCryst Pharmaceuticals, Inc. BioCryst is a biotechnology company that designs, optimizes and develops novel drugs that block enzymes involved in cancer, viral infections and autoimmune diseases. Group VAT registration number You can contact us here. Data delayed 15 minutes unless otherwise indicated.

The company was founded by William M.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 2. Amarin Corporation plc. AMRN 1. TG Therapeutics Inc common stock.

Key events shows relevant news articles on days with large price movements. Ardelyx Inc. ARDX 5. Amarin Corporation plc. AMRN 2. TG Therapeutics Inc common stock. TGTX 1.

Nasdaq bcrx

See all ideas. See all brokers. EN Get started. Market closed Market closed. No trades. BCRX chart. Today 0. Key stats. Market capitalization. Dividend yield indicated.

Wa dog grooming academy

Represents the company's profit divided by the outstanding shares of its common stock. Employees FY. When is the next BioCryst Pharmaceuticals, Inc. Durham, North Carolina United States. Net cash used or generated in financing activities such as dividend payments and loans. Keep track of upcoming events with our Earnings Calendar. First quarter earnings: EPS exceeds analyst expectations while revenues lag behind May Price to earnings Ratio TTM. News Browse. A near test what is ba. Names Dr. About BioCryst Pharmaceuticals, Inc. No longer forecast to breakeven Feb Net change in cash The amount by which a company's cash balance increases or decreases in an accounting period.

.

Earnings per share. Return on assets. Keep reading Keep reading. BCRX chart. Last Reported Earnings Dec 31, Cash from operations. What is BioCryst Pharmaceuticals, Inc. Net change in cash The amount by which a company's cash balance increases or decreases in an accounting period. Jon P. Dividend yield. AUPH 1. Revenue to profit conversion.